Fingerprint
Dive into the research topics of 'A phase I trial of combined ridaforolimus and MK-2206 in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of combined ridaforolimus and MK-2206 in patients with advanced malignancies
Shilpa Gupta, Guillem Argilés, Pamela N. Munster, Antoine Hollebecque, Olav Dajani, Jonathan D. Cheng, Ruixue Wang, Ann Swift, Alessandra Tosolini, Sarina A. Piha-Paul
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations